Coastal Investment Advisors, Inc. Clene Inc. Transaction History

Coastal Investment Advisors, Inc.

  • $211 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024
BUY
$0.31 - $0.44 $930 - $1,320
3,000 Added 18.75%
19,000 $6,000
Q4 2023

Jan 19, 2024
BUY
$0.26 - $0.55 $4,160 - $8,800
16,000 New
16,000 $4,000

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email